Sitemap > Clinical Trials > Psychiatric, Addictive & Sleep Disorders
- An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression
- An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
- Staccato™ Alprazolam for Inhalation in Panic Attack
- Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
- MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia.
- Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
- An 8 Week Study to Evaluate Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
- Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
- Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
- FAST - A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
- Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia
- GSK1014802 Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
- Study Evaluating RGH-188 in the Treatment of Patients With Acute Mania
- AZD6765 for Treatment Resistant Depression
- A Study to Assess Facilitation of the Discontinuation of Zolpidem by Ramelteon Administration in Subjects With Chronic Insomnia
- Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
- Varenicline Adjunctive Treatment in Schizophrenia
- Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects
- MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia
- A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With ORG 50081.
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- Antidepressant Medication and Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
- Olanzapine Treatment of Patients With Bipolar I Disorder
- Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-Episode Psychosis-a Pilot Study
- A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
- Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
- A Study of the Use of Combination of Anti-Cholinergic and Minor Tranquilliser in the Treatment of Non-Cardiac Chest Pain - a Double Blind Placebo Controlled Study
- Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
- The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
- Quetiapine Efficacy in Bipolar Depression Study
- Seroquel Long-Term NIS for Schizophrenia Patients
- A Safety and Efficacy Study of ABT-089 in Children With Attention Deficit-Hyperactivity Disorder (ADHD)
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
- Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
- An Eight-Week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
- A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
- Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
- Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
- Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone
- Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
- Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
- Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
- Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia
- A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence
- High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable
- A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers
- Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
- A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
- Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
- Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
- Study of Paliperidone ER in Adolescents and Young Adults With Autism
- Luasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia
- Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-Gene
- Antibodies to Digoxin for Bipolar Disorder
- SA4503 8-Week Study in Major Depressive Disorder (MDD)
- Study to Evaluate the Effectiveness of Certain SSRI Antidepressants During Pregnancy and Evaluate Newborn Outcomes
- A Safety and Tolerability Study of ABT-089 in Children With Attention Deficit-Hyperactivity Disorder (ADHD)
- A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
- Multidose PK Study of Staccato Loxapine
- Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
- A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
- Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
- Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
- A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
- Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
- A Randomized Long-Term Safety Study of Org 50081 in Elderly Outpatients With Chronic Primary Insomnia Examining the Effects of 1.5 mg or 3.0 mg of Org 50081
- Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months
- Efficacy and Safety Study of Oreg 50081 in Elderly Patients
- DOUBLE-BLIND, FOUR WEEK TRIAL OF [S,S]-REBOXETINE AND ATOMOXETINE IN ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
- Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
- Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia
- A Clinical Evaluation of BW430C (Lamotrigine) in Bipolar I Disorder - Long-Term Extension of Study SCA104779 -
- Prevention of Post-Traumatic Seizures With Levetiracetam
- Ceftriaxone in the Management of Bipolar Depression
- Levetiracetam in the Management of Bipolar Depression
- A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression.
- The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents
- A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.
- A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
- Chantix for Treating Cocaine Dependence
- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects (Zyprexa)
- Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
- A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia
- Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
- BL-1020 Dose Finding Study
- A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
- Optimal Duration of Olanzapine Add-on Therapy in Major Depression (OLA-D)
- A Study of GW856553X For the Treatment of Depression
- A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
- The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Major Depressive Disorder
- Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
- Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder? (Consta)
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt (VarenSmoke)
- Bupropion in the Treatment of Methamphetamine Dependence
- Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
- Gabapentin for Smoking Cessation
- Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
- An Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With a Mood Disorder
- Dose-Response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
- Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking?
- The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
- Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients
- Effect of AQW051 in Patients With Memory Impairment
- Pregabalin (Lyrica) for the Treatment of Essential Tremor
- Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training
- A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study
- A Safety, Efficacy and Tolerability Study of SEP-225289
- Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
- Memantine and Cognitive Dysfunction in Bipolar Disorder
- Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS
- Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)
- Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
- Extension Study of Long-Term Safety and Efficacy of Pregabalin as Monotherapy (Lyrica) in Patients With Partial Seizures.
- Efficacy of Lu AA21004 in the Prevention of Relapse of Major Depressive Episodes
- Treating Alcohol Withdrawal With Oral Baclofen
- Adherence and Long-Term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
- Preventing Epilepsy After Traumatic Brain Injury With Topiramate (PEPTO)
- Galantamine Effects on Cognitive Function in Abstinent Cocaine Users
- Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?
- Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder
- Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia
- Vigabatrin for Treatment of Cocaine Dependence
- An Open Label, Double-Blind Discontinuation Study of Quetiapine XR in Social Anxiety Disorder
- Comparison of Two Types of Family Therapy and Fluoxetine (Prozac) in the Treatment of Adolescent Anorexia Nervosa
- Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
- A 12-Week, Double-Blind, Placebo-Controlled, Trial of Duloxetine Versus Placebo in the Treatment of Binge Eating Disorder and Comorbid Depressive Disorder
- Add-on Simvastatin in Schizophrenia Trial (ASSIST)
- A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia
- Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
- Bupropion and Restless Legs Syndrome
- Pharmacokinetics of Staccato Zaleplon
- Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder
- Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia
- Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression
- Safety and Efficacy of Olanzapine in the Long-Term Treatment for Bipolar I Disorder, Depressed
- Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression
- Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 In GAD Subjects
- A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
- Study Evaluating Multiple Ascending Dose in Schizophrenia Patients
- Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia (SCRP)
- A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients
- A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia
- The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome
- Topiramate Treatment of Problem Drinkers
- Nicotine Patch Pretreatment for Smoking Cessation in PTSD
- Vigabatrin Ph 2a Cocaine Interaction Study
- Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
- An Eight-Week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (COMPASS)
- A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
- A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence (1D)
- Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis (CBD-CT1)
- Staccato® Loxapine Treatment of Schizophrenic Patients With Agitation
- Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
- A Dose Ranging Study of Modafinil for Methamphetamine Dependence
- A Canadian Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia (SPECTRUM)
- Pharmacogenetic Clinical Trial of Nepicastat FOR Post Traumatic Stress Disorder (PTSD)
- Safety and Tolerability Study of ABT-089 in Children With Attention Deficit-Hyperactivity Disorder (ADHD)
- Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
- Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
- A Single Dose Bioequivalence Study Of Two Formulations Of Nicotine Lozenges
- A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
- Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager (shared care)
- A 4-Week, Randomized, Rater-Blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
- Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
- Early Intervention for Post Traumatic Stress Disorder (PTSD)
- Memantine and Cognitive Dysfunction in Bipolar Disorder
- Safety, Tolerability and Efficacy Study of ABT-089 in Adult With Attention Deficit-Hyperactivity Disorder (ADHD)
- A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia.
- A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder
- Cymbalta for Depression as a Complication of Bereavement
- Efficacy of Bifeprunox in Patients With Schizophrenia
- Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
- A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
- Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia
- A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
